Clinical Trial Update: Effect of rhGM-CSF on the Healing of Venous Leg Ulcers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rhGM-CSF for healing venous leg ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer

Drugs mentioned

• RhGM-CSF (sargramostim (recombinant human granulocyte-macrophage colony-stimulating factor))

Snippet

Sponsor: Reponex Pharmaceuticals A/S | Conditions: Venous Leg Ulcer | Phase 2 | Status: UNKNOWN